Hemagglutinin-esterase cannot be considered as a candidate for designing drug against COVID-19.
Mol Divers
; 25(3): 1999-2000, 2021 Aug.
Article
en En
| MEDLINE
| ID: mdl-34241772
ABSTRACT
We read with interest the article by Patel et al. on the identification of potential inhibitors of coronavirus hemagglutinin-esterase. The authors considered hemagglutinin-esterase as a glycoprotein of SARS-CoV-2 and selected hemagglutinin-esterase as a target to identify potential inhibitors using a combination of various computational approaches, and however, SARS-CoV-2 genome lacks hemagglutinin-esterase gene; thus, hemagglutinin-esterase does not exist in SARS-CoV-2 particle.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Asunto principal:
Antivirales
/
Diseño de Fármacos
/
Terapia Molecular Dirigida
/
Tratamiento Farmacológico de COVID-19
Idioma:
En
Revista:
Mol Divers
Asunto de la revista:
BIOLOGIA MOLECULAR
Año:
2021
Tipo del documento:
Article
País de afiliación:
Irán